Cargando…
Drug repositioning for idiopathic epilepsy using gene expression signature data
Epilepsy is one of the most common neurological disorders, affecting millions of patients with a substantial economic and human burden. About 30-40% of epileptic patients remain un-treated after the therapeutic option. Genetic or idiopathic epilepsy count about 40% of total epilepsy patients, showin...
Autores principales: | Kumar, Pawan, Sheokand, Deepak, Grewal, Annu, Saini, Vandana, Kumar, Ajit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Biomedical Informatics
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465761/ https://www.ncbi.nlm.nih.gov/pubmed/37654844 http://dx.doi.org/10.6026/97320630018845 |
Ejemplares similares
-
DrugSig: A resource for computational drug repositioning utilizing gene expression signatures
por: Wu, Hongyu, et al.
Publicado: (2017) -
Drug repositioning in epilepsy reveals novel antiseizure candidates
por: Brueggeman, Leo, et al.
Publicado: (2018) -
Connecting genetics and gene expression data for target prioritisation and drug repositioning
por: Ferrero, Enrico, et al.
Publicado: (2018) -
Protein-Protein interaction network analyses of human WNT proteins involved in neural development
por: Dahiya, Sween, et al.
Publicado: (2019) -
Insights into Molecular Interactions of human Wnt5b and Frizzled proteins for their role in teratogenicity
por: Dahiya, Sween, et al.
Publicado: (2019)